1323919-50-1

Basic information

• Product Name: 2-(2-fluoro-phenyl)-[1,8]naphthyridine-4-boronic acid
• Synonyms: 2-(2-fluoro-phenyl)-[1,8]naphthyridine-4-boronic acid
• CAS NO: 1323919-50-1
• Molecular Weight: 268.055
• Mol File: 1323919-50-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(2-fluoro-phenyl)-[1,8]naphthyridine-4-boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-fluoro-phenyl)-[1,8]naphthyridine-4-boronic acid(1323919-50-1)
• EPA Substance Registry System: 2-(2-fluoro-phenyl)-[1,8]naphthyridine-4-boronic acid(1323919-50-1)

Safety Data

• Hazardous Substances Data: 1323919-50-1(Hazardous Substances Data)

Downstream Products

• 1323920-02-0 C₃₁H₂₉FN₆O₃ 
• 1323917-72-1 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[2,7]naphthyridin-1-ylamine 
• 1323917-74-3 N-{4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[2,7]naphthyridin-1-yl}-acetamide 
• 1323920-13-3 C₂₂H₁₃FN₄O 
• 1353967-40-4 8-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-quinazolin-4-ylamine 
• 1353968-20-3 2-(2-fluoro-phenyl)-4-[5-(1-methyl-1H-pyrazol-4-yl)-isoquinolin-8-yl]-[1,8]naphthyridine 
• 1353967-88-0 2-(2-fluoro-phenyl)-4-(4-methoxy-[2,6]naphthyridin-1-yl)-[1,8]naphthyridine 
• 1353970-49-6 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[1,7]naphthyridine 7-oxide 
• 1353967-68-6 1-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-4-methoxy-pyrido[3,4-d]pyridazine 
• 1353970-11-2 2-(2-fluoro-phenyl)-4-(8-nitro-2-oxy-isoquinolin-5-yl)-[1,8]naphthyridine 
• 1353967-72-2 8-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-ylamine 
• 1353970-08-7 3-amino-2-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-isonicotinonitrile 
• 1353968-69-0 2-(2-fluoro-phenyl)-4-(6-oxy-[2,6]naphthyridin-1-yl)-[1,8]naphthyridine 
• 1353969-30-8 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[1,7]naphthyridine 

Relevant articles and documents

2,4-DIARYL - SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER

The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particu

Hetaryl-[1,8]naphthyridine derivatives

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.